ArticleJournal of thrombosis and haemostasis : JTH2020
Type and dose of heparin in Covid-19: Reply.
Article in Journal of thrombosis and haemostasis : JTH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05509647 (Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients - an Observational Study.), which is not on this map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients - an Observational Study.
Who cites it
13 citing papers in PubMed, 24 citations in OpenAlex.
- The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients.Open medicine (Warsaw, Poland) · 2022Review
- Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports.Internal medicine (Tokyo, Japan) · 2021Article
- Hemostatic alterations in COVID-19.Haematologica · 2021Article
- Hematological Abnormalities in COVID-19: A Narrative Review.The American journal of tropical medicine and hygiene · 2021Review
- Deep vein thrombosis with pulmonary thromboembolism in a case of severe COVID-19 pneumonia.BMJ case reports · 2021Article
- Portal Vein Thrombosis-a Rare Complication of SARS-CoV-2 Infection.SN comprehensive clinical medicine · 2021Article
- COVID-19, thromboembolic risk, and Virchow's triad: Lesson from the past.Clinical cardiology · 2020Review
- Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2020Review
- COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate.Indian pediatrics · 2020Review
- Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19.British journal of haematology · 2020Observational
- The delights and perils of publishing, knowledge-sharing and critique during a pandemic: Observations from COVID-19 coagulopathies.Thrombosis research · 2020Article
- Mechanisms of Stroke in COVID-19.Cerebrovascular diseases (Basel, Switzerland) · 2020Review
- Thromboembolic disease in COVID-19 patients: A brief narrative review.Journal of intensive care · 2020Review
Corrections and comments
- Comment on
Authors and funding
8 authors at 7 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.